Search research articles
Contact Us
Filters
Showing results (1-10 of 141) with videos related to
Page
of 15
Sort By:
Journal of the National Cancer Institute
|
March 23, 2013
Response
Julien Péron, Benoit You
Journal of Clinical Pharmacology
|
March 24, 2011
Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab
Benoit You, Eric X Chen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2020
Reply to J. R. Lurain et al
Benoit You, Pierre-Adrien Bolze, Francois Golfier
Annals of Surgical Oncology
|
October 27, 2021
ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection
Vahan Kepenekian, Julien Péron, Benoit You, et al.
Biomarkers in Medicine
|
June 17, 2024
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer
Pauline Corbaux, Olivier Colomban, Aurore Carrot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review
Benoit You, Hui K Gan, Gregory Pond, et al.
Mathematical Biosciences
|
November 4, 2010
Computational analysis of the influence of the microenvironment on carcinogenesis
David Basanta, Benjamin Ribba, Emmanuel Watkin, et al.
Therapie
|
June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]
Emilie Hénin, Benoit You, Brigitte Tranchand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 17, 2015
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group-174 Phase III Trial
Benoit You, Wei Deng, Emilie Hénin, et al.
Journal of the National Cancer Institute
|
April 12, 2012
Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer
Hui K Gan, Benoit You, Gregory R Pond, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 141) with videos related to
Sort By:
Page
of 15
Journal of the National Cancer Institute
|
March 23, 2013
Response
Julien Péron, Benoit You
Journal of Clinical Pharmacology
|
March 24, 2011
Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab
Benoit You, Eric X Chen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2020
Reply to J. R. Lurain et al
Benoit You, Pierre-Adrien Bolze, Francois Golfier
Annals of Surgical Oncology
|
October 27, 2021
ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection
Vahan Kepenekian, Julien Péron, Benoit You, et al.
Biomarkers in Medicine
|
June 17, 2024
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer
Pauline Corbaux, Olivier Colomban, Aurore Carrot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review
Benoit You, Hui K Gan, Gregory Pond, et al.
Mathematical Biosciences
|
November 4, 2010
Computational analysis of the influence of the microenvironment on carcinogenesis
David Basanta, Benjamin Ribba, Emmanuel Watkin, et al.
Therapie
|
June 22, 2007
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation]
Emilie Hénin, Benoit You, Brigitte Tranchand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 17, 2015
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group-174 Phase III Trial
Benoit You, Wei Deng, Emilie Hénin, et al.
Journal of the National Cancer Institute
|
April 12, 2012
Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer
Hui K Gan, Benoit You, Gregory R Pond, et al.
Page
of 15